Fortrea Holdings Inc.

NasdaqGS:FTRE Stock Report

Market Cap: US$1.5b

Fortrea Holdings Past Earnings Performance

Past criteria checks 0/6

Fortrea Holdings has been growing earnings at an average annual rate of 22.6%, while the Life Sciences industry saw earnings growing at 12.7% annually. Revenues have been growing at an average rate of 2.4% per year.

Key information

22.6%

Earnings growth rate

-269.2%

EPS growth rate

Life Sciences Industry Growth21.5%
Revenue growth rate2.4%
Return on equity-14.7%
Net Margin-7.1%
Next Earnings Update08 Nov 2024

Recent past performance updates

Recent updates

Would Fortrea Holdings (NASDAQ:FTRE) Be Better Off With Less Debt?

Aug 16
Would Fortrea Holdings (NASDAQ:FTRE) Be Better Off With Less Debt?

Fortrea Holdings: Still Many Question Marks On This CRO Play

May 12

Fortrea: High Risk And Low Upside Potential

Feb 13

Fortrea Holdings Inc.'s (NASDAQ:FTRE) Low P/S No Reason For Excitement

Feb 08
Fortrea Holdings Inc.'s (NASDAQ:FTRE) Low P/S No Reason For Excitement

Fortrea Holdings' (NASDAQ:FTRE) Soft Earnings Are Actually Better Than They Appear

Nov 23
Fortrea Holdings' (NASDAQ:FTRE) Soft Earnings Are Actually Better Than They Appear

Revenue & Expenses Breakdown

How Fortrea Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:FTRE Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 243,015-2153980
31 Mar 243,077-913400
31 Dec 233,109-33370
30 Sep 232,957533570
30 Jun 232,9431273490
31 Mar 233,0111683220
31 Dec 223,0961932800
31 Dec 213,058983030
31 Dec 202,580-3592680

Quality Earnings: FTRE is currently unprofitable.

Growing Profit Margin: FTRE is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: FTRE is unprofitable, but has reduced losses over the past 5 years at a rate of 22.6% per year.

Accelerating Growth: Unable to compare FTRE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: FTRE is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-4.7%).


Return on Equity

High ROE: FTRE has a negative Return on Equity (-14.75%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies